Hisanori Machida

Oridonin, a diterpenoid purified from<i>Rabdosia rubescens</i>, inhibits the proliferation of cells from lymphoid malignancies in association with blockade of the NF-κB signal pathways

Takayuki Ikezoe, Yang Yang, Kentaro Bandobashi et al. · Molecular Cancer Therapeutics · 2005 · 151 citations · Full text

Medicine, Oncology, Pharmacology +15

Molecular polymerase chain reaction diagnosis of pulmonary mucormycosis caused by <i>Cunninghamella bertholletiae</i>

Makoto Kobayashi, Kazuto Togitani, Hisanori Machida et al. · Respirology · 2004 · 35 citations

Life Sciences, Infectious Diseases, Microbiology +17

Epstein–Barr virus (EBV)‐positive pyothorax‐associated lymphoma (PAL): chromosomal integration of EBV in a novel CD2‐positive PAL B‐cell line

Masanori Daibata, Takahiro Taguchi, Yuiko Nemoto et al. · British Journal of Haematology · 2002 · 33 citations

Life Sciences, Infectious Diseases, Oncology +16

Differential gene‐expression profiling in the leukemia cell lines derived from indolent and aggressive phases of CD56⁺ T‐cell large granular lymphocyte leukemia

Masanori Daibata, Yoshinobu Matsuo, Hisanori Machida et al. · International Journal of Cancer · 2004 · 33 citations · Full text

Life Sciences, Molecular Biology, Oncology +16

Pretreatment eosinophil counts as a predictive biomarker in non‐small cell lung cancer patients treated with immune checkpoint inhibitors

Eiji Takeuchi, Kensuke Kondo, Yoshio Okano et al. · Thoracic Cancer · 2023 · 25 citations · Full text

Life Sciences, Immunology, Oncology +17